You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AMG 701

Showing 1 - 25 of 423
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Multiple Myeloma Trial (AMG 701)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • AMG 701
  • (no location specified)
Jun 6, 2022

Trial (AMG 701)

Available
    • AMG 701
    • (no location specified)
    Feb 15, 2022

    Relapsed/Refractory Multiple Myeloma Trial in Worldwide (AMG 701, Pomalidomide, Dexamethasone)

    Active, not recruiting
    • Relapsed/Refractory Multiple Myeloma
    • AMG 701
    • +2 more
    • Scottsdale, Arizona
    • +33 more
    Nov 29, 2022

    Relapsed and/or Refractory Multiple Myeloma Trial in Worldwide (AMG 420)

    Completed
    • Relapsed and/or Refractory Multiple Myeloma
    • AMG 420
    • Park Ridge, Illinois
    • +9 more
    Dec 1, 2022

    Relapsed or Refractory Multiple Myeloma, Relapsed or Refractory Acute Myeloid Leukemia Trial in Worldwide (AMG 176, Azacitidine,

    Recruiting
    • Relapsed or Refractory Multiple Myeloma
    • Relapsed or Refractory Acute Myeloid Leukemia
    • AMG 176
    • +2 more
    • Duarte, California
    • +23 more
    Feb 9, 2022

    Secondary Hyperparathyroidism, Chronic Kidney Disease Trial in Worldwide (Etelcalcetide, Cinacalcet)

    Completed
    Has Results
    • Secondary Hyperparathyroidism
    • Chronic Kidney Disease
    • Beijing, Beijing, China
    • +89 more
    Apr 5, 2021

    Lung Adenocarcinoma, Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma Trial in Guam, United

    Recruiting
    • Lung Adenocarcinoma
    • +5 more
    • Birmingham, Alabama
    • +712 more
    Nov 9, 2022

    Late-onset Pompe Disease Trial in Gainesville, London (Respiratory muscle strength measurements by different techniques.)

    Terminated
    Has Results
    • Late-onset Pompe Disease
    • Respiratory muscle strength measurements by different techniques.
    • Gainesville, Florida
    • +1 more
    Apr 11, 2022

    Dyslipidemia Trial in Worldwide (Evolocumab)

    Completed
    • Dyslipidemia
    • Aalst, Belgium
    • +84 more
    Mar 8, 2022

    Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial

    Not yet recruiting
    • Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency
    • +2 more
    • INZ-701
    • Control Arm (Conventional Therapy)
    • (no location specified)
    Sep 18, 2023

    Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial

    Not yet recruiting
    • Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
    • +2 more
    • (no location specified)
    Feb 15, 2023

    Healthy Subjects Trial in Madison (AMG 510)

    Completed
    • Healthy Subjects
    • AMG 510
    • Madison, Wisconsin
      Covance Clinical Research Unit, Inc
    Nov 3, 2022

    Advanced Solid Tumors Trial in Worldwide (AMG 994, AMG 404)

    Active, not recruiting
    • Advanced Solid Tumors
    • AMG 994
    • AMG 404
    • Duarte, California
    • +16 more
    Nov 16, 2022

    Advanced Solid Tumors Trial (AMG 355, Pembrolizumab)

    Not yet recruiting
    • Advanced Solid Tumors
    • (no location specified)
    Nov 9, 2023

    Healthy Volunteers Trial in Madison (AMG 510, Metformin)

    Completed
    • Healthy Volunteers
    • Madison, Wisconsin
      Covance Clinical Research Unit
    Jan 9, 2023

    Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation Trial (Sodium Fusidate, Placebo)

    Not yet recruiting
    • Cystic Fibrosis
    • Cystic Fibrosis Pulmonary Exacerbation
    • Sodium Fusidate
    • Placebo
    • (no location specified)
    Dec 14, 2022

    MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors Trial (AMG 193, IDE397)

    Not yet recruiting
    • MTAP-null Non-Small-Cell Lung Cancer
    • MTAP-null Solid Tumors
    • (no location specified)
    Jul 27, 2023

    Hyperlipidemia Trial in Worldwide (Evolocumab, Ezetimibe, Placebo to Evolocumab)

    Completed
    Has Results
    • Hyperlipidemia
    • Evolocumab
    • +6 more
    • Birmingham, Alabama
    • +243 more
    Nov 4, 2022

    Chronic Graft-versus-Host Disease (cGVHD) Trial in Randwick (AMG 592, Placebo)

    Completed
    • Chronic Graft-versus-Host Disease (cGVHD)
    • AMG 592
    • Placebo
    • Randwick, New South Wales, Australia
      Research Site
    May 23, 2023

    Chronic Graft-versus-host Disease (cGVHD) Trial in Aventura (AMG 592, Placebo)

    Completed
    • Chronic Graft-versus-host Disease (cGVHD)
    • AMG 592
    • Placebo
    • Aventura, Florida
      Research Site
    May 16, 2023

    Heart Failure, Healthy Volunteer Trial in Worldwide (AMG 986 IV, AMG 986 PO, Placebo PO)

    Terminated
    Has Results
    • Heart Failure
    • Healthy Volunteer
    • AMG 986 IV
    • +3 more
    • Anaheim, California
    • +24 more
    Mar 30, 2022

    Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Philadelphia, Greenville, San Antonio (AMG 820)

    Completed
    • Advanced Malignancy
    • +5 more
    • AMG 820
    • Philadelphia, Pennsylvania
    • +2 more
    Jan 18, 2023

    Acceleromyography- and Electromyography-based Neuromuscular

    Not yet recruiting
    • Neuromuscular Blockade
    • TOF-Watch®；DELSYS® Wireless surface EMG
    • Wuhan, Hubei, China
      Department of Anaesthesiology, Tongji Hospital of Tongji Medical
    Dec 15, 2022

    Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Worldwide (AMG820 and pembrolizumab)

    Completed
    Has Results
    • Pancreatic Cancer
    • +2 more
    • AMG820 and pembrolizumab
    • Atlanta, Georgia
    • +14 more
    Jan 18, 2023

    Vitiligo Trial in United States (AMG 714, Placebo, nbUVB phototherapy)

    Recruiting
    • Vitiligo
    • AMG 714
    • +2 more
    • Irvine, California
    • +7 more
    Dec 14, 2022